Roche NimbleGen, BioDiscovery to Team on CGH Analysis Tools | GenomeWeb
NEW YORK (GenomeWeb News) – Roche said today that its Roche NibleGen subsidiary has inked an alliance with Los Angeles-based BioDiscovery to offer a combination of products targeting comparative genomic hybridization.
 
The pact will combine new high-density, 2.1 million probe arrays from Roche NimbleGen with BioDiscovery’s Nexus Copy Number software foe use in whole-genome CGH analysis. Under the alliance, the firms will co-market and co-promote their products and services to scientists worldwide.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.